Loading insider details...
Beta
Latest Form 4 (Sep 29, 2026): Exercise/Conversion of 13,400 ORIC shares, $58.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 29, 2026 | Oric Pharmaceuticals, Inc. (ORIC) | Exercise/Conversion | 13,400 | $58.4K |
| Sep 25, 2026 | Oric Pharmaceuticals, Inc. (ORIC) | Exercise/Conversion | 600 | $2.6K |
| Aug 28, 2026 | Oric Pharmaceuticals, Inc. (ORIC) | Exercise/Conversion | 52,000 | $226.7K |
| Feb 26, 2026 | Oric Pharmaceuticals, Inc. (ORIC) | Exercise/Conversion | 52,000 | $226.7K |
| Jan 6, 2026 | Oric Pharmaceuticals, Inc. (ORIC) | Grant/Award | 206,500 | n/a |
| Dec 17, 2025 | Oric Pharmaceuticals, Inc. (ORIC) | Exercise/Conversion | 29,333 | n/a |
| Oct 8, 2025 | Oric Pharmaceuticals, Inc. (ORIC) | Exercise/Conversion | 11,000 | $48.0K |
| Jul 2, 2025 | Oric Pharmaceuticals, Inc. (ORIC) | Sale | 20,000 | $201.0K |
| Jun 24, 2025 | Oric Pharmaceuticals, Inc. (ORIC) | Sale | 584 | $5.8K |
| Jun 13, 2025 | Oric Pharmaceuticals, Inc. (ORIC) | Sale | 300 | $3.0K |